Mural Oncology plc

MURA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$128,514-$207,447-$189,807-$175,433
Dep. & Amort.$3,512$2,567$1,540$1,474
Deferred Tax$0$0-$15,011-$14,452
Stock-Based Comp.$5,081$24,109$11,931$11,504
Change in WC-$6,046-$13,478$7,748$5,787
Other Non-Cash-$2,578$0$15,011$14,452
Operating Cash Flow-$128,545-$194,249-$168,588-$156,668
Investing Activities
PP&E Inv.-$92-$3,452-$5,511-$4,385
Net Acquisitions$67$0$0$0
Inv. Purchases-$167,305$0$0$0
Inv. Sales/Matur.$142,000$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$25,330-$3,452-$5,511-$4,385
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$196$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$468,811$174,099$161,053
Financing Cash Flow$196$468,811$174,099$161,053
Forex Effect$0$0$0$0
Net Chg. in Cash-$153,679$271,110$0$0
Supplemental Information
Beg. Cash$271,110$0$0$0
End Cash$117,431$271,110$0$0
Free Cash Flow-$128,637-$197,701-$174,099-$161,053